.png){kind=icon}
.png){kind=icon}
Return
Translational molecular imaging: Thrombosis imaging with positron emission tomography
.png){kind=icon}
OA
AI
DOI：10.1016/j.nuclcard.2024.101848.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
A key focus of cardiovascular medicine is the detection, treatment, and prevention of disease, with a move towards more personalized and patient-centred treatments. To achieve this goal, novel imaging approaches that allow for early and accurate detection of disease and risk stratification are needed. At present, the diagnosis, monitoring, and prognostication of thrombotic cardiovascular diseases are based on imaging techniques that measure changes in structural anatomy and biological function. Molecular imaging is emerging as a new tool for the non-invasive detection of biological processes, such as thrombosis, that can improve identification of these events above and beyond current imaging modalities. At the forefront of these evolving techniques is the use of high- sensitivity radiotracers in conjunction with positron emission tomography imaging that could revolutionise current diagnostic paradigms by improving our understanding of the role and origin of thrombosis in a range of cardiovascular diseases.
Keywords:
Thrombosis
Positron emission tomography
Molecular imaging
Radiotracers
Cardiovascular disease
Journal
IF:
2.7
Papers:
5.9K
Citations:
4.1K